Surveillance and Follow-up Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Surveillance and Follow-up. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Surveillance and Follow-up Indian Medical PG Question 1: Which of the following is not true about osteosarcoma?
- A. Seen in the metaphyseal region of the long bones
- B. Lung metastasis is common
- C. Secondary osteosarcoma is seen in older age groups
- D. Most commonly arises in the epiphyseal region (Correct Answer)
Surveillance and Follow-up Explanation: ***Most commonly arises in the epiphyseal region***
- This statement is **FALSE** - osteosarcoma most commonly arises in the **metaphyseal region** of long bones, particularly around the knee (distal femur, proximal tibia) and proximal humerus [1].
- The metaphysis is the region where bone growth is most active, which explains why osteosarcoma preferentially occurs there.
- The epiphysis (growth plate region) is **not** the typical location for osteosarcoma.
*Seen in the metaphyseal region of the long bones*
- This is **TRUE** - osteosarcoma characteristically arises in the **metaphyseal regions** of long bones, especially around the knee and proximal humerus where growth is most active [1].
*Lung metastasis is common*
- This is **TRUE** - the lungs are the most common site of distant metastasis in osteosarcoma, occurring in up to 80% of patients who develop metastatic disease [1].
- Pulmonary metastasis significantly impacts prognosis and treatment [1].
*Secondary osteosarcoma is seen in older age groups*
- This is **TRUE** - while primary osteosarcoma affects children and young adults (peak 10-20 years), **secondary osteosarcoma** occurs in older patients, typically arising in association with Paget's disease, prior radiation therapy, or bone infarcts [1].
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1200-1202.
Surveillance and Follow-up Indian Medical PG Question 2: Distant bone metastases can be best detected by which of the following imaging techniques?
- A. Bone scan (Correct Answer)
- B. CT
- C. Intravenous venogram
- D. PET scan
Surveillance and Follow-up Explanation: ***Bone scan***
- A **bone scan** is highly sensitive for detecting **osteoblastic activity**, which is characteristic of most bone metastases.
- It involves injecting a **radioactive tracer** (usually technetium-99m methylene diphosphonate) that accumulates in areas of increased bone turnover, making it excellent for surveying the entire skeletal system.
*PET scan*
- While a **PET scan** (Positron Emission Tomography) can detect bone metastases, especially with **FDG-PET**, it is generally more expensive and may not be as sensitive for purely **osteoblastic lesions** as a bone scan.
- Its primary role is often in assessing metabolic activity of the primary tumor and other distant soft tissue metastases.
*CT*
- **CT scans** (Computed Tomography) are excellent for assessing bone anatomy, cortical destruction, and soft tissue involvement, but they are generally less sensitive for detecting early or widespread **osseous metastatic disease** compared to a bone scan.
- CT provides detailed anatomical information but may miss early **marrow involvement** that alters bone metabolism.
*Intravenous venogram*
- An **intravenous venogram** is an imaging technique used to visualize veins, primarily for detecting **thrombosis** or venous insufficiency.
- It has no role in the detection of **bone metastases**, as it provides no information about bone structure or metabolic activity.
Surveillance and Follow-up Indian Medical PG Question 3: What is the average time interval between radiation exposure and genesis of post-radiation osteosarcoma?
- A. 16 yrs (Correct Answer)
- B. 4 yrs
- C. 8 yrs
- D. 2 yrs
Surveillance and Follow-up Explanation: ***16 yrs***
- The latency period for **radiation-induced osteosarcomas** is typically long, often exceeding a decade.
- Studies have shown the average interval between therapeutic radiation and the development of osteosarcoma to be around **10-20 years**, with 16 years being a well-supported average.
*4 yrs*
- A 4-year interval is generally too short for the development of a **secondary osteosarcoma** after radiation exposure.
- While other radiation-induced pathologies might manifest earlier, the transformation to osteosarcoma requires a sustained period of genetic damage and cellular changes.
*8 yrs*
- An 8-year latency period is still relatively short for most radiation-induced osteosarcomas to develop.
- While some cases might occur within this timeframe, the average and modal latency periods are typically longer, reflecting the multi-step process of **carcinogenesis**.
*2 yrs*
- A 2-year interval is exceptionally rare for the development of a **radiation-induced osteosarcoma**.
- This short period does not align with the known biological mechanisms and latency associated with radiation-induced bone malignancies.
Surveillance and Follow-up Indian Medical PG Question 4: What is the significance of a 2-year post-treatment surveillance period in paucibacillary leprosy?
- A. To monitor for treatment compliance during active therapy
- B. To assess the effectiveness of multibacillary leprosy treatment protocols
- C. To detect early signs of drug resistance in ongoing treatment
- D. To identify relapses, reactions, and neurological complications after treatment completion (Correct Answer)
Surveillance and Follow-up Explanation: ***To identify relapses, reactions, and neurological complications after treatment completion***
- The 2-year post-treatment surveillance period for **paucibacillary leprosy** is crucial for monitoring for **relapses** which can occur even after successful multidrug therapy (MDT).
- It also allows for the early detection and management of **leprosy reactions** (e.g., Type 1 reversal reactions) and **neurological complications** such as nerve damage, which can develop or progress after treatment completion.
*To monitor for treatment compliance during active therapy*
- Monitoring for **treatment compliance** occurs *during* the active 6-month MDT period for paucibacillary leprosy, not primarily in the 2-year post-treatment surveillance phase.
- While compliance is essential for successful treatment, the post-treatment period is focused on after-effects.
*To assess the effectiveness of multibacillary leprosy treatment protocols*
- This surveillance period is specifically for **paucibacillary leprosy**, which has a different treatment regimen and surveillance duration (6 months MDT followed by 2 years surveillance) compared to multibacillary leprosy (12 months MDT followed by 5 years surveillance).
- The effectiveness of multibacillary treatment protocols would be assessed over a longer period following completion of its own specific MDT.
*To detect early signs of drug resistance in ongoing treatment*
- Detection of **drug resistance** is typically assessed *during* treatment if a patient is not responding clinically or shows signs of worsening, or in cases of relapse where drug resistance might be suspected as the cause.
- While possible, the primary purpose of post-treatment surveillance is broader than just drug resistance; it encompasses all potential adverse long-term outcomes.
Surveillance and Follow-up Indian Medical PG Question 5: A 45 yrs male presented with an expansile lesion in the centre of femoral metaphysis. The lesion shows Endosteal scalloping and punctuate calcifications. Most likely diagnosis is:
- A. Fibrous Dysplasia
- B. Chondrosarcoma (Correct Answer)
- C. Simple bone cyst
- D. Osteosarcoma
Surveillance and Follow-up Explanation: ***Chondrosarcoma***
- An **expansile lesion** within the **femoral metaphysis** with **endosteal scalloping** and **punctate calcifications** is highly characteristic of a chondrosarcoma.
- The punctate/arc-and-ring calcifications are typical for cartilage matrix, which is the hallmark of chondrosarcoma, and the patient's age (45 years) fits the typical demographic.
*Fibrous Dysplasia*
- This condition presents as a **ground-glass matrix** on imaging, not punctate calcifications.
- While it can be expansile, it typically does not show prominent endosteal scalloping with cartilage calcifications.
*Simple bone cyst*
- Simple bone cysts are typically **lytic lesions** that do not show punctate calcifications or aggressive endosteal scalloping.
- They are often **fluid-filled** and common in children/adolescents, whereas this patient is 45 years old.
*Osteosarcoma*
- Osteosarcomas are characterized by **osteoid matrix formation** and often have a more aggressive appearance with a **sunburst or spiculated periosteal reaction** and bone formation, not punctate cartilage calcifications.
- While it can be expansile, the calcification pattern described points away from osteosarcoma.
Surveillance and Follow-up Indian Medical PG Question 6: Most common site of osteogenic sarcoma is:
- A. Tibia, lower end
- B. Femur, upper end
- C. Tibia, upper end
- D. Femur, lower end (Correct Answer)
Surveillance and Follow-up Explanation: ***Femur, lower end***
- The **distal femur** is the most common site for osteogenic sarcoma, accounting for approximately **40% of all cases** [1].
- This region, along with the **proximal tibia**, are the most frequent locations for this primary bone tumor [1].
*Tibia, lower end*
- While osteogenic sarcoma can occur in the **tibia**, the **proximal end** is more commonly affected than the distal end.
- The distal tibia is a less frequent site compared to the distal femur or proximal tibia.
*Femur, upper end*
- The **proximal femur** is a recognized site for osteogenic sarcoma, but it is less common than the **distal femur**.
- Tumors in the proximal femur account for a smaller percentage of overall osteosarcoma cases.
*Tibia, upper end*
- The **proximal tibia** is the **second most common site** for osteogenic sarcoma, frequently affected after the distal femur [1].
- However, the question asks for the *most* common site, which remains the distal femur.
Surveillance and Follow-up Indian Medical PG Question 7: In the treatment of osteosarcoma, all of the following chemotherapy agents are used EXCEPT:
- A. High dose methotrexate
- B. Cyclophosphamide
- C. Vincristine (Correct Answer)
- D. Doxorubicin
Surveillance and Follow-up Explanation: **Explanation:**
The standard of care for **Osteosarcoma** involves a multimodal approach consisting of neoadjuvant chemotherapy, wide local surgical excision (limb-salvage surgery), and adjuvant chemotherapy.
**Why Vincristine is the correct answer:**
Vincristine is a vinca alkaloid that inhibits microtubule formation. While it is a cornerstone in the treatment of **Ewing’s Sarcoma** (as part of the VAC/VAI regimen), it has no proven efficacy against Osteosarcoma. Therefore, it is not included in standard osteosarcoma protocols.
**Analysis of other options:**
* **High-dose Methotrexate (with Leucovorin rescue):** This is a primary agent used to inhibit dihydrofolate reductase, crucial for treating high-grade osteosarcoma.
* **Doxorubicin (Adriamycin):** An anthracycline that remains one of the most effective drugs for bone sarcomas.
* **Cyclophosphamide:** While not part of the primary "MAP" (Methotrexate, Adriamycin, Platinum) regimen, it is frequently used in **second-line or salvage therapy** for recurrent or refractory osteosarcoma.
**High-Yield NEET-PG Pearls:**
1. **Standard Regimen (MAP):** The most common chemotherapy combination for Osteosarcoma is **M**ethotrexate, **A**driamycin (Doxorubicin), and **P**latin (Cisplatin).
2. **Ewing’s Sarcoma Regimen:** Remember the mnemonic **VAC** (Vincristine, Adriamycin, Cyclophosphamide) or **VAI** (Ifosfamide instead of Cyclophosphamide).
3. **Prognostic Marker:** The most important prognostic factor in osteosarcoma is the **histologic response to neoadjuvant chemotherapy** (Huvos grade; >90% necrosis indicates a good prognosis).
4. **Radio-resistance:** Osteosarcoma is generally radio-resistant, making chemotherapy and surgery the mainstays of treatment.
Surveillance and Follow-up Indian Medical PG Question 8: Which of the following statements is true regarding hemangioma of the bone?
- A. Occurs commonly in skull bones.
- B. Requires observation as it is premalignant.
- C. Hamartomatous in origin. (Correct Answer)
- D. Forms 10-12% of bone tumors.
Surveillance and Follow-up Explanation: **Explanation:**
**Hemangioma of the bone** is a benign, slow-growing vascular lesion. The correct answer is **C** because these lesions are considered **hamartomatous** in origin—meaning they are a malformation of normal vascular tissue (capillary, cavernous, or venous) rather than a true neoplastic growth.
**Analysis of Options:**
* **Option A (Incorrect):** While hemangiomas can occur in the skull, the **vertebral column** (specifically the thoracic and lumbar spine) is the most common site, followed by the skull.
* **Option B (Incorrect):** Hemangiomas are strictly **benign** and have no documented malignant potential. Most are asymptomatic and require observation only because they are harmless, not because they are premalignant.
* **Option D (Incorrect):** They are relatively common incidental findings (found in ~10% of autopsies), but they account for only **0.7% to 1%** of all primary bone tumors, not 10-12%.
**High-Yield Clinical Pearls for NEET-PG:**
* **Radiological Signs:**
* **Vertebra:** Shows a characteristic **"Jail-bar"** or **"Corduroy cloth"** appearance due to the thickening of vertical trabeculae.
* **Skull:** Shows a classic **"Sunburst"** or **"Spoke-wheel"** pattern of trabeculation.
* **Management:** Most are asymptomatic and require no treatment. If symptomatic (e.g., spinal cord compression), options include radiotherapy, embolization, or surgical decompression.
* **Polka-dot Sign:** On CT scans of the vertebrae, the cross-section of thickened vertical trabeculae appears as multiple small dots.
Surveillance and Follow-up Indian Medical PG Question 9: What is the most common bone involved in hemangioma?
- A. Femur
- B. Tibia
- C. Pelvis
- D. Vertebrae (Correct Answer)
Surveillance and Follow-up Explanation: **Explanation:**
**Hemangioma** is a benign, slow-growing vascular tumor characterized by the proliferation of blood vessels. It is the most common primary benign tumor of the spine.
1. **Why Vertebrae is Correct:**
The **vertebral column** (specifically the thoracic and lumbar spine) is the most common site for skeletal hemangiomas. They are usually asymptomatic and discovered incidentally on imaging. Pathologically, they involve the replacement of bone marrow by vascular channels, leading to the characteristic **"Polka-dot" appearance** on axial CT scans and a **"Corduroy cloth" or "Jail-bar" appearance** (vertical striations) on lateral X-rays due to the thickening of remaining vertical trabeculae.
2. **Why Other Options are Incorrect:**
* **Femur and Tibia:** While these are common sites for other bone tumors like Osteoid Osteoma or Osteosarcoma, they are rare sites for hemangiomas. When hemangiomas occur in long bones, they are often located in the craniofacial bones (skull) rather than the appendicular skeleton.
* **Pelvis:** Although the pelvis contains significant marrow, it is a much less frequent site for hemangiomas compared to the axial skeleton (spine and skull).
**High-Yield Clinical Pearls for NEET-PG:**
* **Most common site:** Vertebrae (Thoracic > Lumbar).
* **Second most common site:** Skull (Calvarium).
* **Radiological Signs:** "Jail-bar" appearance (X-ray), "Polka-dot" sign (CT), and high signal intensity on both T1 and T2 weighted images (MRI) due to fat content.
* **Management:** Most are asymptomatic and require no treatment. Symptomatic cases (causing cord compression) may require radiotherapy, embolization, or surgery.
Surveillance and Follow-up Indian Medical PG Question 10: Which of the following is NOT an epiphyseal tumor?
- A. Chondroblastoma
- B. Osteoclastoma
- C. Clear cell chondrosarcoma
- D. Simple bone cyst (Correct Answer)
Surveillance and Follow-up Explanation: The location of a bone tumor relative to the growth plate (epiphysis, metaphysis, or diaphysis) is a high-yield diagnostic marker in orthopaedics.
### **Explanation of the Correct Answer**
**D. Simple Bone Cyst (SBC):** This is a **metaphyseal** lesion. SBCs (also known as Unicameral Bone Cysts) typically occur in the proximal humerus or femur of children. They originate near the growth plate in the metaphysis and "migrate" toward the diaphysis as the bone grows. They are never primarily epiphyseal.
### **Analysis of Incorrect Options (Epiphyseal Tumors)**
The epiphysis is an uncommon site for tumors; therefore, the few that occur there are frequently tested:
* **A. Chondroblastoma:** The classic epiphyseal tumor in children/adolescents (before physeal closure). It is often referred to as "Codman’s tumor."
* **B. Osteoclastoma (Giant Cell Tumor):** The most common epiphyseal tumor in adults (after physeal closure). It characteristically extends from the metaphysis into the epiphysis up to the subchondral bone.
* **C. Clear Cell Chondrosarcoma:** A rare, low-grade malignant variant of chondrosarcoma that specifically involves the epiphysis of long bones (often the femoral head), mimicking a GCT or chondroblastoma.
### **NEET-PG High-Yield Pearls**
* **Mnemonic for Epiphyseal Lesions:** "**C**-**G**-**C**" (**C**hondroblastoma, **G**iant Cell Tumor, **C**lear Cell Chondrosarcoma).
* **Age Distinction:** If the physis is **open** (child) → Chondroblastoma; if the physis is **closed** (adult) → Giant Cell Tumor.
* **SBC Radiographic Sign:** Look for the **"Fallen Leaf Sign"** (a pathological fracture where a cortical fragment settles at the bottom of the fluid-filled cyst).
* **Diaphyseal Tumors:** Remember **Ewing’s Sarcoma**, Osteoid Osteoma, and Adamantinoma.
More Surveillance and Follow-up Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
